The global clot management devices market is growing significantly due to large geriatric population and high incidences of cardiovascular diseases, such as stroke and heart attacks.
The increasing demand for minimally invasive surgeries and massive unexplored clot management devices market in the emerging economies are creating ample opportunities for the growth of the global clot management devices market. The advanced research and development facilities and new product developments by the major players are supporting the demand for cost-effective and efficient clot management devices.
Explore Report at: www.psmarketresearch.com/market-analysis/clot-management-devices-market
In the global clot management devices market, a trend of increasing usage of percutaneous procedures for clot management has been observed. Clot management refers to the treatment of patients with blood clots, such as pulmonary embolism, arterial blood clots and deep vein thrombosis.
Blood clot or thrombus is formed by platelets and fibrin in blood to stop bleeding from injured blood vessels. However, sometimes a blood clot is formed inside a blood vessel even though when it is not required.
This may lead to serious medical consequences, such as deep vein thrombosis and pulmonary embolism. There are several risk-leading factors, such as smoking, certain surgeries, inherited blood clotting diseases, pregnancy, immobility, high cholesterol level and certain heart diseases, which may cause blood clots.
Geographically, North America leads the global clot management devices market due to the high healthcare expenditure, aging population, increasing healthcare provider’s compliance for percutaneous thrombectomy devices and high prevalence of heart attacks and stroke. In addition, the technological advancements and high investment by major players for the development of clot management devices are fueling the growth of the clot management devices market in North America.
Asia-Pacific is the fastest growing region in the global clot management devices market, owing to improving healthcare infrastructure, growing healthcare expenditure, increasing demand for minimally invasive surgeries and high prevalence of heart diseases. Moreover, the Asia-Pacific clot management devices market is growing rapidly due increasing research and development activities, growing adoption of percutaneous devices among patients and healthcare providers, and presence of large number of patients suffering from hemostasis disorders in emerging economies, such as India and China.
The key players operating in the global clot management devices market are Applied Medical Resources Corporation, EKOS Corporation (a BTG International group company), St. Jude Medical Inc., Medtronic, Boston Scientific Corporation, Volcano Corporation, AngioDynamics, Johnson & Johnson Services Inc., Sorin Group, Bayer AG, Abbott, Stryker and Edwards Lifesciences Corporation.
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...
For more information:Make an Inquiry about this report HERE!